James V Cassella Insider Trading $ALXA Alexza Pharmaceuticals Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James V Cassella.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James V Cassella. James V Cassella is EVP, R&D and CSO in Alexza Pharmaceuticals Inc. ($ALXA) and SVP, Research & Development in Alexza Pharmaceuticals Inc. ($ALXA).
James V Cassella in Alexza Pharmaceuticals Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James V Cassella: EVP, R&D and CSO, SVP, Research & Development
Holdings: 62,495 shares
Latest Transaction: Apr 02 2013
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of James V Cassella in Alexza Pharmaceuticals Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2013 | ALXA | Alexza Pharmaceuti ... | Cassella James V | EVP, R&D and CSO | Option Exercise | A | 4.42 | 43,750 | 193,375 | 43,750 | |
| Apr 02 2013 | ALXA | Alexza Pharmaceuti ... | Cassella James V | EVP, R&D and CSO | Grant | A | 4.42 | 43,750 | 193,375 | 62,495 | 18.7 K to 62.5 K (+233.40 %) |
| Feb 08 2013 | ALXA | Alexza Pharmaceuti ... | Cassella James V | EVP, R&D and CSO | Grant | A | 0.00 | 17,795 | 0 | 18,745 | 950 to 18.7 K (+1,873.16 %) |
| Dec 27 2012 | ALXA | Alexza Pharmaceuti ... | Cassella James V | EVP, R&D and CSO | Sell | S | 4.90 | 4,558 | 22,316 | 950 | 5.5 K to 950 (-82.75 %) |
| Aug 29 2012 | ALXA | Alexza Pharmaceuti ... | Cassella James V | EVP, R&D and CSO | Sell | S | 4.14 | 10,000 | 41,364 | 5,508 | 15.5 K to 5.5 K (-64.48 %) |
| Jul 30 2012 | ALXA | Alexza Pharmaceuti ... | Cassella James V | EVP, R&D and CSO | Option Exercise | A | 3.47 | 25,000 | 86,750 | 25,000 | |
| Jul 30 2012 | ALXA | Alexza Pharmaceuti ... | Cassella James V | EVP, R&D and CSO | Option Exercise | A | 3.47 | 15,000 | 52,050 | 15,000 | |
| Jun 08 2012 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Sell | S | 0.34 | 46,222 | 15,628 | 157,801 | 204 K to 157.8 K (-22.66 %) |
| May 14 2012 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Grant | A | 0.00 | 100,000 | 0 | 204,023 | 104 K to 204 K (+96.13 %) |
| Mar 26 2012 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Grant | A | 0.00 | 46,222 | 0 | 104,023 | 57.8 K to 104 K (+79.97 %) |
| Aug 01 2011 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 1.53 | 200,000 | 306,000 | 200,000 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 1.23 | 21,672 | 26,657 | 21,672 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | D | 2.81 | 32,508 | 91,347 | 0 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 1.23 | 27,500 | 33,825 | 27,500 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | D | 4.35 | 55,000 | 239,250 | 0 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 1.23 | 1,174 | 1,444 | 1,174 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | D | 7.50 | 4,696 | 35,220 | 0 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 1.23 | 11,250 | 13,838 | 11,250 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | D | 8.89 | 45,000 | 400,050 | 0 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 1.23 | 714 | 878 | 714 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | D | 11.70 | 2,856 | 33,415 | 0 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 1.23 | 9,750 | 11,993 | 9,750 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | D | 7.20 | 39,000 | 280,800 | 0 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 1.23 | 4,129 | 5,079 | 4,129 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | D | 8.00 | 16,517 | 132,136 | 0 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 1.23 | 796 | 979 | 796 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | D | 6.88 | 3,185 | 21,913 | 0 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 1.23 | 27,273 | 33,546 | 27,273 | |
| Feb 24 2011 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | D | 8.00 | 109,090 | 872,720 | 0 | |
| Jan 21 2011 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Grant | A | 0.00 | 45,582 | 0 | 57,801 | 12.2 K to 57.8 K (+373.04 %) |
| Dec 30 2009 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 2.37 | 49,626 | 117,614 | 49,626 | |
| Dec 18 2009 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Sell | S | 2.13 | 12,408 | 26,391 | 12,214 | 24.6 K to 12.2 K (-50.39 %) |
| Dec 18 2009 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Sell | S | 2.20 | 4,284 | 9,428 | 24,622 | 28.9 K to 24.6 K (-14.82 %) |
| Dec 18 2009 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Sell | S | 2.41 | 7,732 | 18,612 | 28,906 | 36.6 K to 28.9 K (-21.10 %) |
| Feb 26 2009 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 2.10 | 27,277 | 57,282 | 27,277 | |
| Feb 26 2009 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Grant | A | 0.00 | 24,419 | 0 | 36,638 | 12.2 K to 36.6 K (+199.84 %) |
| Jan 26 2009 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 2.81 | 32,508 | 91,347 | 32,508 | |
| Jul 11 2008 | ALXA | Alexza Pharmaceuti ... | Cassella James V | SVP, Research & Dev ... | Option Exercise | A | 4.35 | 55,000 | 239,250 | 55,000 |
Page: 1